Kimberly-Clark's Risky Bet on Tylenol Amid Political Heat
Kimberly-Clark, a big name in consumer goods, just made a bold move. They bought Kenvue, the company behind Tylenol. But this deal didn't go over well with Wall Street. Their stock took a huge hit, the worst since the big crash in 1987. Shares dropped by 15%, which is a lot. Why did they do it? They're betting Tylenol can handle some serious heat. President Trump an...